全文获取类型
收费全文 | 2576篇 |
免费 | 163篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 98篇 |
妇产科学 | 64篇 |
基础医学 | 377篇 |
口腔科学 | 91篇 |
临床医学 | 286篇 |
内科学 | 558篇 |
皮肤病学 | 47篇 |
神经病学 | 134篇 |
特种医学 | 283篇 |
外科学 | 268篇 |
综合类 | 25篇 |
预防医学 | 229篇 |
眼科学 | 39篇 |
药学 | 134篇 |
中国医学 | 9篇 |
肿瘤学 | 83篇 |
出版年
2023年 | 19篇 |
2022年 | 27篇 |
2021年 | 62篇 |
2020年 | 34篇 |
2019年 | 64篇 |
2018年 | 86篇 |
2017年 | 48篇 |
2016年 | 59篇 |
2015年 | 53篇 |
2014年 | 78篇 |
2013年 | 100篇 |
2012年 | 124篇 |
2011年 | 128篇 |
2010年 | 110篇 |
2009年 | 108篇 |
2008年 | 124篇 |
2007年 | 112篇 |
2006年 | 78篇 |
2005年 | 92篇 |
2004年 | 61篇 |
2003年 | 68篇 |
2002年 | 58篇 |
2001年 | 61篇 |
2000年 | 61篇 |
1999年 | 43篇 |
1998年 | 58篇 |
1997年 | 61篇 |
1996年 | 72篇 |
1995年 | 55篇 |
1994年 | 50篇 |
1993年 | 53篇 |
1992年 | 25篇 |
1991年 | 28篇 |
1990年 | 23篇 |
1989年 | 49篇 |
1988年 | 48篇 |
1987年 | 42篇 |
1986年 | 48篇 |
1985年 | 39篇 |
1984年 | 30篇 |
1983年 | 19篇 |
1982年 | 35篇 |
1981年 | 21篇 |
1980年 | 10篇 |
1979年 | 14篇 |
1978年 | 9篇 |
1977年 | 14篇 |
1976年 | 13篇 |
1975年 | 15篇 |
1974年 | 8篇 |
排序方式: 共有2749条查询结果,搜索用时 15 毫秒
1.
Rodrigo Pacheco 《中国神经再生研究》2019,(12)
正The emerging role of gut microbiota as a key player in the development of neurodegenerative disorders:Mammals have evolved togetherwithcommensalmicrobiotatoestablishasymbioticrelationship in which they regulate reciprocally by synthesizing and responding to several common chemical substances. In this regard, gut microbiota 相似文献
2.
L Laforest E Van Ganse G Devouassoux S Chretin L Osman G Bauguil Y Pacheco G Chamba 《The European respiratory journal》2006,27(1):42-50
French asthma patients may be supervised by general practitioners (GPs) and/or specialists. Therefore, this study examined asthma management in patients exclusively supervised by specialists (SPE), GPs, (GP) and both (GP+SPE group), and compared the findings. Asthma patients were consecutively recruited in 348 pharmacies. Each patient completed a questionnaire providing data on personal characteristics, asthma management, perception of disease and asthma supervision. Asthma control was measured using the Asthma Control Test. Questionnaires were linked to computerised records of medications which had been dispensed before inclusion in the study. From the 1,256 patients (mean age = 36.1 yrs, 54.3% females), 11.4, 36.6, and 52.0% were placed in the SPE, GP, and GP+SPE groups, respectively. During the previous 4 weeks, most patients in the SPE group were properly controlled (52.2 versus 26.4 and 21.5% in GP and GP+SPE groups, respectively). The SPE group made more use of fixed combinations of long-acting beta agonist and inhaled corticosteroid, while receiving less short-acting beta agonists, antitussives and antibiotics. Striking differences in symptoms and asthma management were observed according to the type of asthma supervision. The current results strongly support the need to improve the management of asthma in primary care, and the coordination of care between general practitioners and specialists. 相似文献
3.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
4.
Jose M. Fernández-Cebrián Peter Vorwald Kuborn Mar Pardo de Lama Alfonso Sanjuanbenito Dehesa Manuel Nevado Santos Pedro A. Pacheco Martínez Beatriz Fernández-Escudero 《Clinical & translational oncology》2005,7(3):101-109
Colorectal cancer is one of the best studied of all malignant diseases interms of genetics and/or molecular prognostic factors. These factors, and relationships with prognosis, may have important implications especially in the design of surgical and adjuvant chemo-radiotherapy options. However, the true prognostic significance of all known factors has yet to be realised. We have reviewed the literature with specific focus on the role of molecular markers involved in prognosis and the prediction of response to adjuvant treatment. 相似文献
5.
6.
7.
8.
Adrià Arboix Lluis García-Eroles Emili Comes Montserrat Oliveres Miquel Balcells Gustavo Pacheco Cecilia Targa 《European journal of neurology》2003,10(4):429-435
We assessed predictors of spontaneous early neurological recovery after acute ischemic stroke by means of multivariate analysis in a cohort of 1,473 consecutive patients treated at one academic center. At hospital discharge, spontaneous neurological improvement or good outcome was defined as grades 0-2 of the Rankin scale, and poor outcome (no improvement or in-hospital death) as grades 3-5. Spontaneous recovery of neurological deficit at the time of discharge from the hospital was observed in 16% of patients with cerebral infarction (n = 238). Dysarthria-clumsy hand syndrome improved in 44% of patients and was the only variable significantly associated with in-hospital functional recovery in three logistic regression models that in addition to lacunar syndromes, included demographic variables, cardiovascular risk factors, and clinical variables [odds ratio (OR) 2.56], neuroimaging findings (OR 2.48), and outcome data (OR 2.39), respectively. Clinical factors related to severity of infarction available at stroke onset have a predominant influence upon in-hospital outcome and may help clinicians to assess prognosis more accurately. Our work gives a contribution into prognostic factors after acute ischemic stroke. With regard to patterns of stroke, dysarthria-clumsy hand syndrome was a significant predictor of spontaneous in-hospital recovery in ischemic stroke patients. 相似文献
9.
Metastatic tumors to the oral cavity are uncommon. Most of these cases involve the mandible or the maxilla. Rarely, metastasis occurs to the oral soft tissues from a distant primary tumor. The lung and breast are the most common primary sites. It is extremely rare to have an oral soft-tissue metastasis from a carcinoma of the colon. A case of primary adenocarcinoma of the colon with metastasis to the soft tissues of the mouth is described. Three similar case reports are reviewed. A metastatic lesion to the oral cavity could be the first indication of the presence of a primary tumor. 相似文献